3-IODOBENZYL-GUANIDINE HEMISULFATE
3物価
選択條件:
ブランド
- Sigma-Aldrich Japan
パッケージ
- 5mg
- 25mg
- 生産者Sigma-Aldrich Japan
- 製品番號(hào)I9890
- 製品説明 ≥98% (HPLC and TLC)
- 英語(yǔ)製品説明3-IODOBENZYL-GUANIDINE HEMISULFATE ≥98% (HPLC and TLC)
- 包裝単位5mg
- 価格¥24720
- 更新しました2021-03-23
- 購(gòu)入
- 生産者Sigma-Aldrich Japan
- 製品番號(hào)I0328000
- 製品説明 European Pharmacopoeia (EP) Reference Standard
- 英語(yǔ)製品説明3-IODOBENZYL-GUANIDINE HEMISULFATE European Pharmacopoeia (EP) Reference Standard
- 包裝単位
- 価格¥35200
- 更新しました2021-03-23
- 購(gòu)入
- 生産者Sigma-Aldrich Japan
- 製品番號(hào)I9890
- 製品説明 ≥98% (HPLC and TLC)
- 英語(yǔ)製品説明3-IODOBENZYL-GUANIDINE HEMISULFATE ≥98% (HPLC and TLC)
- 包裝単位25mg
- 価格¥95400
- 更新しました2024-03-01
- 購(gòu)入
生産者 | 製品番號(hào) | 製品説明 | 包裝単位 | 価格 | 更新時(shí)間 | 購(gòu)入 |
---|---|---|---|---|---|---|
Sigma-Aldrich Japan | I9890 | ≥98% (HPLC and TLC) 3-IODOBENZYL-GUANIDINE HEMISULFATE ≥98% (HPLC and TLC) |
5mg | ¥24720 | 2021-03-23 | 購(gòu)入 |
Sigma-Aldrich Japan | I0328000 | European Pharmacopoeia (EP) Reference Standard 3-IODOBENZYL-GUANIDINE HEMISULFATE European Pharmacopoeia (EP) Reference Standard |
¥35200 | 2021-03-23 | 購(gòu)入 | |
Sigma-Aldrich Japan | I9890 | ≥98% (HPLC and TLC) 3-IODOBENZYL-GUANIDINE HEMISULFATE ≥98% (HPLC and TLC) |
25mg | ¥95400 | 2024-03-01 | 購(gòu)入 |
プロパティ
貯蔵溫度 :2-8°C
溶解性 :DMSO: 2 mg/ml; DMSO:PBS (pH 7.2) (1:4): 0.2 mg/ml
外見(jiàn) :A crystalline solid
色 :White to off-white
溶解性 :DMSO: 2 mg/ml; DMSO:PBS (pH 7.2) (1:4): 0.2 mg/ml
外見(jiàn) :A crystalline solid
色 :White to off-white
安全情報(bào)
絵表示(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
注意喚起語(yǔ): | Warning | |||||||||||||||||||||||||||||||||||
危険有害性情報(bào): |
|
|||||||||||||||||||||||||||||||||||
注意書き: |
|
説明
m-Iodobenzylguanidine (MIBG) is an analogue of norepinephrine with anticancer activity. It inhibits cell growth in a panel of human and mouse leukemia, fibrosarcoma, melanoma, and neuroblastoma cell lines when used at a concentration of 20 μg/ml and reduces clonogenic survival of L1210 leukemia cells in a concentration-dependent manner. MIBG increases survival in N1E155 and L1210 mouse xenograft models when administered at doses of 40 and 20 mg/kg, respectively. It selectively accumulates in chromaffin tissues and tumors and formulations containing radiolabeled forms of MIBG have been used as imaging agents in the diagnosis and treatment of neuroendocrine tumors. MIBG also inhibits ADP-ribose linkage to membrane proteins in turkey erythrocyte membranes.供給者とメーカー
BOC Sciences
TargetMol Chemicals Inc.
LEAPCHEM CO., LTD.
Aladdin Scientific
QUALITY CONTROL SOLUTIONS LTD.
ShangHai Caerulum Pharma Discovery Co., Ltd.
Shanghai EFE Biological Technology Co., Ltd.
MQ (shanghai) Pharmaceuticals Co., Ltd.
Hubei Yangxin Medical Technology Co., Ltd.
Shanghai Hongye Biotechnology Co. Ltd